Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 209 | 1,799 | 3,386 | 5,084 | 6,599 |
| TOTAL | $928 | $1,902 | $3,729 | $5,601 | $7,454 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 200 | 221 | 243 | 264 | 234 |
| TOTAL | $200 | $221 | $243 | $264 | $234 |
| Total Assets | $1,128 | $2,123 | $3,971 | $5,865 | $7,688 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,449 | 731 | 847 | 648 | 760 |
| Accrued Expenses | 99 | 98 | 98 | 97 | 97 |
| TOTAL | $2,791 | $2,028 | $2,315 | $2,697 | $2,960 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 576 | 701 | 773 | 1,068 | 1,339 |
| Other Non-Current Liabilities | 79 | 106 | 132 | 157 | 144 |
| TOTAL | $79 | $106 | $132 | $157 | $144 |
| Total Liabilities | $2,870 | $2,134 | $2,447 | $2,854 | $3,104 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,570 | 1,570 | 1,570 | 1,570 | 1,570 |
| Common Shares | 9 | 2 | 9 | 9 | 9 |
| Retained earnings | -117,778 | -115,805 | -113,164 | -112,327 | -110,255 |
| TOTAL | $-1,742 | $-11 | $1,524 | $3,010 | $4,585 |
| Total Liabilities And Equity | $1,128 | $2,123 | $3,971 | $5,865 | $7,688 |